Comparison of engraftment level in different organs at 50 weeks after transplantation
ID* . | Group . | BM†(%) . | PB (%) . | Spleen (%) . | Thymus (%) . |
---|---|---|---|---|---|
BALB/c | 0 | 0 | 0 | 0 | |
B6.SJL | 82.68 | 93.79 | 98.44 | 95.24 | |
I1 | 0 cGy/40 × 106 | 0.3 | 0 | 0.16 | 0.21 |
I2 | 0 cGy/40 × 106 | 0.13 | 0 | 0 | 0 |
IV4 | 100 cGy/0.4 mg anti-CD40L mAb/40 × 106 | 12.45 | 24.4 | 34.54 | 21.49 |
IV5 | 100 cGy/0.4 mg anti-CD40L mAb/40 × 106 | 0 | 0 | 0 | 0 |
V1 | 100 cGy/0.8 mg anti-CD40L mAb/40 × 106 | 4.22 | 11.26 | 24.21 | 10.58 |
V2 | 100 cGy/0.8 mg anti-CD40L mAb/40 × 106 | 18.34 | 30.05 | 58.64 | 24.79 |
ID* . | Group . | BM†(%) . | PB (%) . | Spleen (%) . | Thymus (%) . |
---|---|---|---|---|---|
BALB/c | 0 | 0 | 0 | 0 | |
B6.SJL | 82.68 | 93.79 | 98.44 | 95.24 | |
I1 | 0 cGy/40 × 106 | 0.3 | 0 | 0.16 | 0.21 |
I2 | 0 cGy/40 × 106 | 0.13 | 0 | 0 | 0 |
IV4 | 100 cGy/0.4 mg anti-CD40L mAb/40 × 106 | 12.45 | 24.4 | 34.54 | 21.49 |
IV5 | 100 cGy/0.4 mg anti-CD40L mAb/40 × 106 | 0 | 0 | 0 | 0 |
V1 | 100 cGy/0.8 mg anti-CD40L mAb/40 × 106 | 4.22 | 11.26 | 24.21 | 10.58 |
V2 | 100 cGy/0.8 mg anti-CD40L mAb/40 × 106 | 18.34 | 30.05 | 58.64 | 24.79 |